IP Library Granted Patent US 11,833,117
Granted Patent B2
US 11,833,117 · App. 17/004,648 · Granted Dec 5, 2023

Tableted cannabinoid chewing gum with layered structure

Inventors: Heidi Ziegler Bruun (Vejle, DK); Dorthe Schackinger Boesen (Vejle, DK); Ane Eriksen (Vejle, DK)
Assignee: NordicCan A/S
A61K9/0058A23G4/08A23G4/10A23G4/12A23G4/20A61K31/352A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,833,117
App. No.
17/004,648
Granted
Dec 5, 2023
Kind
B2
Abstract

A tableted chewing gum composition for oral administration of cannabinoids includes a plurality of particles, including a first population of particles having water-insoluble gum base and a second population of particles having water-soluble chewing gum ingredients. The composition constitutes at least two layers, where a first layer of the composition has water-insoluble gum base and a second layer of the composition, which is cohered to and adjacent to the first layer, has water-soluble chewing gum ingredients. The second layer is free of water-insoluble gum base, and the composition includes one or more cannabinoids.

Claims (31)

1. A pressed chewing gum tablet comprising a plurality of particles, including a first population of particles comprising water-insoluble gum base and a second population of particles comprising water-soluble chewing gum ingredients, and the pressed chewing gum tablet constituting at least two layers, wherein

a) a first layer of the pressed gum tablet comprises water-insoluble gum base and

b) a second layer of the pressed chewing gum tablet, which is cohered to and adjacent to the first layer, comprises water-soluble chewing gum ingredients, the second layer being free of water-insoluble gum base, and wherein the pressed chewing gum tablet comprises one or more cannabinoids.

2. The pressed chewing gum tablet according to claim 1 , wherein the pressed shewing gum tablet consists of two layers.

3. The pressed chewing gum tablet according to claim 1 , wherein the weight ratio of the first layer relative to the second layer is from 1:10 to 10:1.

4. The pressed chewing gum tablet according to claim 1 , wherein the weight ratio of the first layer relative to the second layer is from 1:2 to 2:1.

5. The pressed chewing gum tablet according to claim 1 , wherein the pressed chewing gum tablet consists of three layers where the first layer is the middle layer, and the second layer is cohered to and adjacent to one side of the first layer, and a third layer is cohered to and adjacent to the opposite side of the first layer.

6. The pressed chewing gum tablet according to claim 5 , wherein the weight ratio of the first layer relative to the second layer relative to the third layer is from 1:5:5 to 10:1:1.

7. The pressed chewing gum tablet according to claim 5 , wherein the weight ratio of the first layer relative to the second layer relative to the third layer is from 1:3:3 to 3:1:1.

8. The pressed chewing gum tablet according to claim 1 , wherein the pressed chewing gum tablet consists of three layers where the second layer is the middle layer, and the first layer is cohered to and adjacent to one side of the second layer, and a third layer is cohered to and adjacent to the opposite side of the second layer.

9. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids is present in the first population of particles comprising water-insoluble gum base.

10. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids is located in the first layer of the chewing gum composition.

11. The pressed chewing gum tablet according to claim 1 , wherein the content of water-insoluble gum base of the first layer is more than 30% by weight of the first layer.

12. The pressed chewing gum tablet according to claim 1 , wherein the content of water-soluble chewing gum ingredients of the second layer is more than 50% by weight of the second layer.

13. The pressed chewing gum tablet according to claim 1 , wherein the gum base comprising one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base.

14. The pressed chewing gum tablet according to claim 1 , wherein the water-soluble chewing gum ingredients comprise one or more sugar alcohols or one or more sugars in an amount of 35-80% by weight of the tablet.

15. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids is present in a premixture with one or more sugar alcohols, one or more sugars or one or more microcrystalline species.

16. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids comprises at least one phytocannabinoid that is contained in a cannabinoid extract when incorporated in the tablet.

17. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids comprises at least two cannabinoids.

18. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids is selected from the group consisting of a phytocannabinoid, an endocannabinoid and a synthetic cannabinoid.

19. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids comprises palmitoylethanolamide.

20. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids is located in a protein carrier.

21. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids is part of a self-emulsifying drug delivery system.

22. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids is selected from the group consisting of cannabidiol (CBD), cannabidiolic acid (CBDA), cannabidivarin (CBDV), salts and derivatives thereof.

23. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids is selected from the group consisting of tetrahydrocannabinol (THC), tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarin (THCV), salts and derivatives thereof.

24. The pressed chewing gum tablet according to claim 1 , wherein the one or more cannabinoids is selected from the group consisting of cannabichromene (CBC), cannabichromenic acid (CBCV), cannabigerol (CBG), cannabigerol propyl variant (CBGV), cannabicyclol (CBL), cannabinol (CBN), cannabinol propyl variant (CBNV), cannabitriol (CBO), and tetrahydrocannabivarinic acid (THCVA).

25. The pressed chewing gum tablet according to claim 1 , wherein the tablet comprises a further active ingredient different from the one or more cannabinoids.

26. A compressed chewing gum tablet, the tablet comprising a plurality of particles, and the tablet constituting at least two layers, wherein

a) a first layer of the tablet comprises water-insoluble gum base and

b) a second layer of the tablet, which is cohered to and adjacent to the first layer, comprises water-soluble chewing gum ingredients, the second layer being free of water-insoluble gum base, and

wherein the tablet comprises one or more cannabinoids.

Assignments (3)
CHANGE OF NAME Recorded Sep 18, 2020
From: MEDCAN PHARMA A/S
To: NORDICCAN A/S
Reel/Frame 053816/0773 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2020
From: BRUUN, HEIDI ZIEGLER; BOESEN, DORTHE SCHACKINGER; ERIKSEN, ANE
To: FERTIN PHARMA A/S
Reel/Frame 053640/0412 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2020
From: FERTIN PHARMA A/S
To: MEDCAN PHARMA A/S
Reel/Frame 053640/0499 →
Continuity (2)
Continuation 16289770 · Mar 1, 2019
Related Publication 20200390697A1 · Dec 17, 2020
Cited By (1)
US 12,582,602